Preparation and antidiabetic activity of cyclic sulfonylthiourea derivatives

DOI: 10.1002/jps.2600700834

Source and publish data:

Journal of Pharmaceutical Sciences p. 952 - 956 (1981)

Update date:2022-08-03

Topics:

Authors:

Soliman Soliman

Feid-Allah

Mohamed Mohamed

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1002/jps.2600700834

Full text of DOI:10.1002/jps.2600700834

Products guided by the article

Product name:5-methyl-1-{4-[(propyl-thiocarbamoyl)-sulfamoyl]-phenyl}-1H-pyrazole-3-carboxylic acid

Cas No:69180-85-4

R&D Labs maybe for 69180-85-4

Zhejiang Chemicals Import & Export Corporation (ZHECHEM)

Contact:+86-571-87046953

Address:No. 37, Qingchun Road
Lyrin Industrial Corporation Limited

Contact:86-731-82571800

Address:Rm 2408,Asia Economy International Building,Shaoshan Road South,Yuhua District,Changsha,Hunan,China
Anhui Biochem United Pharmaceutical Co., Ltd.

Contact:0086 551 5167062 / 5228268

Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
Global United Biotechnology Inc.

Contact:+86-21-61618568

Address:Room 309, Building 6, NO.135, Jinyu Road, Pudong
Shandong Yuanli Science and Technology Co., Ltd.

Contact:86-0536-6777557

Address:Zhuliu Industiral Park,Changle County

Relevant to this article

Synthesis of α-hederin, δ-hederin, and related triterpenoid saponins

Doi:10.1002/ejoc.200300723
(2004)
Novel Synthesis and Rearrangement of 3,1,5-Benzoxadiazepines

Doi:10.1007/BF00808308
(1988)
Doi:10.1016/S0040-4039(01)94950-0
(1978)
Modular Total Syntheses of the Marine-Derived Resorcylic Acid Lactones Cochliomycins A and B Using a Late-Stage Nozaki-Hiyama-Kishi Macrocyclization Reaction

Doi:10.1021/jo5024602
(2015)
Ionic perylenetetracarboxdiimides: Highly fluorescent and water-soluble dyes for biolabeling

Doi:10.1002/anie.200353208
(2004)
Significant Differences in Biological Parameters between Prodrugs Cleavable by Carboxypeptidase G2 That Generate 3,5-Difluoro-phenol and -aniline Nitrogen Mustards in Gene-Directed Enzyme Prodrug Therapy Systems

Doi:10.1021/jm030966w
(2004)

Article Doi